The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer.


The current management of advanced ovarian cancer consists of aggressive primary cytoreductive surgery (PCS) followed by combination platinum based chemotherapy. Recent studies have suggested that platinum-based chemotherapy may be of benefit in patients with advanced ovarian cancer prior to cytoreductive surgery (neoadjuvant chemotherapy, NACT). The… (More)
DOI: 10.1002/jso.21482


1 Figure or Table